Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Brain Neoplasms × Methylprednisolone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia 5 Leukemia, Myeloid, Acute 4 Myelodysplastic Syndromes 3 Lymphoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Myelomonocytic, Juvenile 2 Hodgkin Disease 2 Shwachman-Diamond Syndrome 1 Primary Immunodeficiency Diseases 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Oropharyngeal Neoplasms 1 Neutropenia, Severe Congenital, Autosomal Recessive 3 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Macrophage Activation Syndrome 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Lymphohistiocytosis, Hemophagocytic 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Biphenotypic, Acute 1 Histiocytosis, Langerhans-Cell 1 Histiocytosis 1 Hemoglobinopathies 1 Cranial Nerve Diseases 1 Burkitt Lymphoma 1 Brain Neoplasms 1

Interventions

Temozolomide 24 Radiosurgery 12 Bevacizumab 12 Radiotherapy 8 Carboplatin 8 pembrolizumab 7 Trastuzumab 6 Erlotinib Hydrochloride 5 abemaciclib 4 Paclitaxel 4 Irinotecan 4 Capecitabine 4 tipifarnib 3 temsirolimus 3 Sirolimus 3 Radiation 3 Mental Status and Dementia Tests 3 Ipilimumab 3 Everolimus 3 Aminolevulinic Acid 3 tucatinib 2 pertuzumab 2 fludarabine 2 durvalumab 2 alovudine 2 Vorinostat 2 Surgical Procedures, Operative 2 Sorafenib 2 Nivolumab 2 NVP-BKM120 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05789589 2026-03-04

ADORATION

Baptist Health South Florida

Phase 1/2 Recruiting

Brain Neoplasms, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡